The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Precisely Controlling the Activation of an Iron-Locked Drug Generator in the Liver Sinusoid to Enhance Barrier Penetration and Reduction of Liver Fibrosis
Abstract
Complex physical barriers and the nanomaterial's clearance mechanism in the liver greatly hinder the feasibility of using a conventional liver-targeting nanoplatform to deliver antifibrotic drugs to pathological sites for the treatment of liver fibrosis. Here, a novel drug delivery strategy was designed to overcome drug penetration barriers in a fibrotic liver and cooperated with oral nattokinase (NKase)-mediated antifibrosis therapy as a proof of concept, which relies on the coadministration of a nanosized iron-locked drug generator (named Pro-HAase) and orally absorbed iron chelator deferasirox (DFX). Such a strategy starts from the rapid accumulation of intravenously injected Pro-HAase in the microcapillaries of the fibrotic liver followed by disrupting the polyphenol-iron coordination inside Pro-HAase by DFX, liberating antifibrotic components, including procyanidine (PA) and hyaluronidase (HAase). Attractively, absorption of DFX requires the sequential processes of traversing the intestinal mucosa and targeting the liver, which enable DFX to preferentially disassemble Pro-HAase accumulated in the liver sinusoid rather than in systemic circulation or other organs, thus avoiding the off-target activation of Pro-HAase and depletion of the normal iron pool. The in situ disassembly process decreases the sequestration of Pro-HAase by cells of the mononuclear phagocyte system and promotes gradient-driven permeation of therapeutic components to surrounding liver tissues within 2 h, accompanied by biliary excretion of the inactive iron-DFX complex. As a result, the cooperation of Pro-HAase and DFX not only allows NKase-mediated therapy to completely reverse liver fibrosis but also suppresses the chronic hepatotoxicity of residual liver iron after multiple doses of Pro-HAase. The high spatiotemporal precision, unique barrier-penetration mechanism, and self-detoxification ability of this strategy will inspire the rational design of analogous iron-locked nanosystems to improve the therapeutic outcomes of liver fibrosis or other liver diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The activation of hepatic stellate cells (HSCs) has long been recognized as a primary source of ECM and a crucial factor in the progression of liver fibrosis (2).”
From Matrix mechanical remodeled carrier-free nanosystem for programmable closed-loop reversal of liver fibrosis via STING alkylation (2025) · cites this paper as [2]
Citations
Cites
Ferroptosis: mechanisms, biology and role in disease
Jiang, X., Stockwell, B. R., & Conrad, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00324-8 · Cited by 7,505
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Tsochatzis, E. A., Bosch, J., & Burroughs, A. K. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60121-5 · Cited by 1,740
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers
Wahsner, J., Gale, E. M., Rodríguez-Rodríguez, A., & Caravan, P. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00363 · Cited by 1,603
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
Noninvasive Imaging of Quantum Dots in Mice
Ballou, B., Lagerholm, B. C., Ernst, L. A., Bruchez, M. P., & Waggoner, A. S. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034153y · Cited by 1,140
Liver sinusoidal endothelial cells: Physiology and role in liver diseases
Poisson, J., Lemoinne, S., Boulanger, C., Durand, F., Moreau, R., Valla, D., & Rautou, P.-E. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.009 · Cited by 1,047
Mechanism of hard-nanomaterial clearance by the liver
Tsoi, K. M., MacParland, S. A., Ma, X.-Z., Spetzler, V. N., Echeverri, J., Ouyang, B., Fadel, S. M., Sykes, E. A., Goldaracena, N., Kaths, J. M., et al. (2016) · Nature Materials · doi:10.1038/nmat4718 · Cited by 1,010
Kim, D., Park, S., Lee, J. H., Jeong, Y. Y., & Jon, S. (2007) · Journal of the American Chemical Society · doi:10.1021/ja071471p · Cited by 876
Research works printed but not linked: 2
- Wang Z., 2015, Altern. Ther. Health Med., 21, 12
- 10.1177/1177271918785130 · DOI · Paper page
Cited by
Precision Phototherapy Enabled by Decoding Complex Microenvironments
Ding, Q., Qi, M., Li, W., Li, M., Xu, J., Kim, Y., Kim, G., Dong, B., Wang, L., & Kim, J. S. (2025) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5c00488 · Cited by 60
Han, H., Yu, D., Liu, Y., Jia, H., & Liu, W. (2025) · Science Advances · doi:10.1126/sciadv.adz4126 · Cited by 7
Wei, C., Shan, X., Huang, Y., Ma, B., Zhao, Z., Fang, Y., Bai, C., Zhang, Z., Zhao, P., Zhang, H., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c16886 · Cited by 5
Huang, S., Wang, K., Ma, Y., Wang, Z., & Tan, M. (2025) · Food Chemistry · doi:10.1016/j.foodchem.2025.146752 · Cited by 3
Theranostic of neutrophilization nanoparticles
Sun, D., Song, B., Sun, W., Li, A., Gao, Z., & Yu, D. (2026) · Progress in Materials Science · doi:10.1016/j.pmatsci.2026.101699 · Cited by 1
Metadata
- Authors
- Sun, Q., Yang, W., Song, Z., Lu, H., Shang, W., Li, H., Yang, Z., Gao, W., Li, Y., Xu, Y., Luo, M., Liu, K., Wu, Q., Xuan, Z., Shen, W., Yang, Y., & Yin, D.
- Affiliations
- Anhui University of Traditional Chinese Medicine (CN)
- Corresponding author
- Shen, Wei
- Yang, Ye
- Yin, Dengke
- ORCID
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2024-11-25
- Volume
- 146
- Issue
- 49
- Pages
- 33784-33803
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W4404696583
- Cited by
- 6
- References
- 62
- Citations by year
- 2026: 3 · 2025: 3
- FWCI
- 0.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Journal of the American Chemical Society (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Anhui Provincial Department of Education (2022AH040077, 2022AH040080, 2023AH030065)
- Anhui University of Chinese Medicine (2021ZC06)
- National Natural Science Foundation of China (52203154)
- Anhui Province (2022xscx100, gxbjZD2022027)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- liver fibrosis, deferasirox, nattokinase, hyaluronidase, procyanidins, liver-targeted drug delivery, iron chelation, liver sinusoids, barrier penetration, antifibrotic therapy, hepatotoxicity, biliary excretion, reticuloendothelial system
- MeSH terms
- Deferasirox, Animals, Humans, Iron, Iron Chelating Agents, Liver, Liver Cirrhosis, Drug Delivery Systems, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Precisely Controlling the Activation of an Iron-Locked Drug Generator in the Liver Sinusoid to Enhance Barrier Penetration and Reduction of Liver Fibrosis. https://app.cochat.ai/papers/10.1021/jacs.4c11988
- The paper
- Sun, Q., Yang, W., Song, Z., Lu, H., Shang, W., Li, H., Yang, Z., Gao, W., Li, Y., Xu, Y., Luo, M., Liu, K., Wu, Q., Xuan, Z., Shen, W., Yang, Y., & Yin, D. (2024). Precisely Controlling the Activation of an Iron-Locked Drug Generator in the Liver Sinusoid to Enhance Barrier Penetration and Reduction of Liver Fibrosis. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.4c11988
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.